Differential role of BCL2 in molecular subtypes of diffuse large B-cell lymphoma.
other · Level V
Where this comes from
- Record sourced from PubMed, PMID 22184285.
- Also identified by DOI 10.1158/1078-0432.CCR-11-2372 and PMC identifier 3531963.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Gene expression profiling has been used to divide diffuse large B-cell lymphoma into distinct molecular subtypes with different outcomes following immunochemotherapy. Recently, researchers have shown much interest in investigating the role of biomarkers, such as BCL2, in predicting outcome in diffuse large B-cell lymphoma, particularly in the context of these molecular subtypes.
Medical subject headings
- Antineoplastic Combined Chemotherapy Protocols
- Lymphoma, Large B-Cell, Diffuse
- Proto-Oncogene Proteins c-bcl-2